📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[ 18 F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism (2025)

First Author: Gillett D

Attributed to: Development of a fluorine-18 radiopharmaceutical to enhance and establish adrenal imaging by positron emission tomography funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.124.268425

PubMed Identifier: 39884776

Publication URI: http://europepmc.org/abstract/MED/39884776

Type: Journal Article/Review

Parent Publication: Journal of Nuclear Medicine

Issue: 3

ISSN: 0161-5505